Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2001)
Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats
European Journal of Pharmacology 415: 157
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (2000)
Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats
European Journal of Pharmacology 389: 173
Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000)
Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro
Methods Find Exp Clin Pharmacol 22: 609
Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000)
Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats
Methods Find Exp Clin Pharmacol 22: 89
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (1999)
Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats
European Journal of Pharmacology 380: 101
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (1999)
Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats
European Journal of Pharmacology 386: 7
Kosasa T, Kuriya Y, Yamanishi Y (1999)
Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats
Japanese Journal of Pharmacology 81: 216